(Q41274494)

29 September 2017

1 reference

title

Iron versus cholesterol--response to dissent by Weintraub et al. (English)

1 reference

29 September 2017

Sullivan JL

1

1 reference

29 September 2017

publication date

1 December 1996

1 reference

Journal of Clinical Epidemiology

29 September 2017

published in

1 reference

29 September 2017

volume

49

1 reference

29 September 2017

issue

12

1 reference

29 September 2017

page(s)

1359-1362

1 reference

Hyperlipidemia versus iron overload and coronary artery disease: yet more arguments on the cholesterol debate

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

The iron paradigm of ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

The complete sequence of the rabbit erythroid cell-specific 15-lipoxygenase mRNA: comparison of the predicted amino acid sequence of the erythrocyte lipoxygenase with other lipoxygenases

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Effect of nutritional iron deficiency on acute and chronic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Effect of iron deficiency on bleomycin-induced lung fibrosis in the hamster

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Iron versus cholesterol--perspectives on the iron and heart disease debate

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Inhibition of iron absorption by cholestyramine. Demonstration of diminished iron stores following prolonged administration

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Iron and the sex difference in heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Quotation bias in reviews of the diet-heart idea

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

Are body iron stores related to the risk of coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2896%2900293-4

7 January 2021

10.1016/S0895-4356(96)00293-4

Identifiers

DOI

1 reference

29 September 2017

1 reference